Sort
21,453 grants matching “tuberculosis”
Sequencing Core
$660,525James C Sacchettini · Harvard Medical School · U19 · FY2015 · AI
New radiotracer development to study immune cell mobilization of granzyme proteolytic activity
$660,398Michael John Evans · University Of California, San Francisco · R01 · FY2023 · AI
Targeting trans-translation to kill M. tuberculosis non-replicating persister cells
$660,266Kenneth C Keiler · Pennsylvania State University, The · R01 · FY2023 · AI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors
$659,945James C Sacchettini · Texas A&M University · U01 · FY2012 · GM
Chemical disarming of drug resistance in Mycobacterium tuberculosis
$659,913Christina Leigh Stallings · Washington University · R01 · FY2020 · AI
A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical Projects
$659,894Michael L Gross · Washington University · R24 · FY2022 · GM
Strategies for tuberculosis control in prisons
$659,869Jason Randolph Andrews · Stanford University · R01 · FY2017 · AI
Novel Biomarkers to Shorten TB Treatment
$659,830David Alland · Rbhs-New Jersey Medical School · R01 · FY2020 · AI
Modeling Core
$659,782Nitin S Baliga · Seattle Children'S Hospital · U19 · FY2018 · AI
Integrative Pharmacology Approach to Understand Mechanisms of TB Drug Resistance
$659,598Eric L Nuermberger · Johns Hopkins University · R01 · FY2014 · AI
Lung immune function in human TB infection and its perturbation by HIV-1.
$659,438David G Russell · Cornell University · R01 · FY2021 · AI
Statistical methods for correlated outcome and covariate errors in studies of HIV/AIDS
$659,345Bryan Earl Shepherd · Vanderbilt University Medical Center · R01 · FY2021 · AI
Predicting tuberculosis outcomes using genotypic and biomarker signatures
$659,272Gillian L Beamer · Tufts University Boston · R01 · FY2022 · HL
Trial of Vitamin D Supplementation to Prevent TB Infection in Schoolchildren
$659,269Ganmaa Davaasambuu · Harvard School Of Public Health · R01 · FY2014 · HL
Statistical methods for correlated outcome and covariate errors in studies of HIV/AIDS
$659,129Bryan Earl Shepherd · Vanderbilt University Medical Center · R01 · FY2022 · AI
pH-Dependent Switching of ESX-1 Substrates in Mycobacterial Pathogenesis
$659,122Patricia A Champion · University Of Notre Dame · R01 · FY2025 · AI
Iron and O2 in the Regulation of P. aeruginosa Virulence
$659,058Michael L. Vasil · University Of Colorado Denver · R37 · FY2008 · AI
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
$659,026Scott K Heysell · University Of Virginia · U01 · FY2024 · AI
Genes And Gene Products As Immunoadjuvants
$658,891Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Structural characterization of MCE transport systems from Mycobacterium tuberculosis
$658,620Gira Bhabha · Johns Hopkins University · R01 · FY2024 · AI
Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin America
$658,567Robert H Gilman · Johns Hopkins University · R01 · FY2019 · AI
Lung immune function in human TB infection and its perturbation by HIV-1.
$658,518David G Russell · Cornell University · R01 · FY2022 · AI
Antibacterial Host Defense
$658,320Robert Munford · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Lung-Protective Mechanisms of Metformin in TB
$658,272Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · HL
Autophagy Against Tuberculosis and HIV
$658,214Vojo P Deretic · University Of New Mexico Health Scis Ctr · R01 · FY2018 · AI